FdaApplication
NDA 215760
Identifiers
- fda_app_no: NDA215760
Properties
| Property | Value |
|---|---|
| applicant_name | ORPHALAN SA |
| application_type | NDA |
| approval_date | 2022-04-28 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CUVRIOR | TRIENTINE TETRAHYDROCHLORIDE | 300MG | TABLET;ORAL |
1 product